I am woefully delinquent in sharing my perspective on the 2010 Roche-sponsored Social Media Summit which took place on the last few days of June and into early July. I'm a few months late, although I must admit, it took me a while to get my brain around what happened. Of course, it was a holiday weekend right after the event, and then my office relocated to Manhattan from the suburbs on July 3, so upon my return from the event, I had some serious unpacking to deal with at work (the good news is the view from my new office is pretty awesome, overlooking the Hudson River (see HERE for a pic I snapped with my phone). Since then, one of my colleagues at work left the firm, so I've assumed many of her duties (as well as my own), so free time for blogging and other social media has been pretty limited. That's likely to be the case for at least the next month or two. Anyway, with all of my excuses out of the way, I can finally share some perspective on the Roche-sponsored summit with you, my readers!
Disclosure: Roche paid for my travel, lodging, and most of my food on this trip. Roche did not ask anyone to blog about the summit, nor did they pitch any products to us, but I have some perspective to share, and want to give acknowledgement where it's due, thus my reason for posting about it today.
Summit About More Than Social Media
First, let me begin by noting that Roche selected just a handful of diabetes bloggers and a few notable others (such as Kitty Castellini and Charlie Cherry), both of whom are much more active in traditional media (specifically radio) than they are internet-based media.
There were also a few individuals who don't fit into such a well-defined category, such as Brandy Barnes (Diabetes Sisters), who reaches out to women with diabetes. If I had to define her work, I'd probably say that her biggest achievement was really not in "new" media specifically, or even in media at all -- but an actual conference (the Diabetes Sisters Conference) that was actually years in development -- an old-fashion get-together (probably an under-statement, but as a guy, I wasn't privy to the event) where people with a common interest descended upon a venue and actually met face-to-face for a few days -- awesome! There's really nothing "2.0" about that, but was still quite a notable accomplishment and contribution to say the least! To be sure, all of these people have some presence online, but their contributions to the diabetes community is probably best associated with their offline presence. Depending on whose definition one chooses to follow, there are certainly hundreds, if not thousands of people in this collective space. In fact, Diabetes Living Today, which is a syndicated radio program, reaches into the millions nationwide.
Perspective: Last Year, This Year
Keep in mind that this all kind of began over a year ago, when the Swiss pharmaceutical, biotechnology and medical device giant Roche reached out to a handful of individuals in the U.S. who were seen as thought leaders in this new, patient-controlled world of social media. Many Pharma companies have gone ahead and plunged into the social media space and bombed big-time! Novo Nordisk, for example, is a company whose 2009 Twitter campaign for Levemir with NASCAR racecar driver Charlie Kimball was rightly criticized for being "sleazy spam" (and those were kind descriptions!). (see HERE for more background on that). Roche was eager to avoid that debacle by asking questions before plowing into the social media space, thus the company had a social media summit at their U.S. headquarters in Indianapolis last summer (see HERE for my post on that event).
The company did demonstrate that they've tried to actually listen to us, and I believe their efforts have been genuine. For example, in the company's Accu-Chek ads, the company is now showing meter readings that look more typical of a person with diabetes. Let me share the presentation they prepared for us:
I have also embedded a sample advertisement Roche is now running so you can see the TV ad for yourselves, and you see the ad and visit the Accu-Chek website to see the spots. I had to watch it carefully, but there really are examples when people in the commercial have readings of 140 mg/dL and 147 mg/dL respectively, and we've been told the actors actually have diabetes themselves ... while the readings were not exactly too far from "normal" for a real person with diabetes (indeed, many PWD's would be delighted with those readings), but it's certainly a lot more genuine than the reading of 106 mg/dL pictured on the package of the meter:
Scott thanks for an excellent summary of what went on. I really like the idea of someone (ADA/JDRF/an other) supporting medical students so that becoming an endo is more attractive financially. I also think that there should be more training for people with diabetes to enable them to help others with diabetes. Kind of like a mini CDE, that might help to slightly relieve the shortage of endos,
I'm over at a fellow diabetic friend's house visiting and we were looking at your blogsite and both agreed that it is one of the best around.
Thank you so much for your thorough firsthand report here, links included in it, and your always excellent blogsite in total. Because of your hard work diabetics everywhere are better off. You are the real diabetes superhero!
Ambre Morley from Novo Nordisk. Your characteristic of our use of Twitter with Charlie Kimball is not quite how we see it, as Twitter is only one small element of the much larger, Race with Insulin campaign. There were several follow ups to the article you posted and I'd like to share with you the overall diabetes awareness campaign that we think has had a big impact. Please let me know at abmo at novonordisk.com if you'd like to discuss.
Thanks, Ambre Morley Associate Director, Product Communications Novo Nordisk
Writer, speaker, brother, son, friend, spouse, advocate for people with autoimmune (type 1) diabetes, thinker, dreamer. Reading and writing is becoming a lost art, but we can learn a lot from reading the medical and scientific literature before drawing conclusions. The press publishes abbreviated facts to fit into limited space, I don't mince words or omit facts.
Download a Dexcom manufacturer coupon to save $200 per 30-day supply of sensors (and an additional $200 on each 3-month transmitter on the G6 model). Visit https://www.dexcom.com/savings-center for details.
Get Freestyle Libre e-Savings Voucher
If you're commercially insured and asked to pay more than $75 for two Freestyle Libre 3 sensors, call Abbott customer care at 1-855-632-8658 (M-F from 8-8 ET) to ask for an "eSavings voucher". Abbott manufacturer vouchers expire at the end of each calendar year and patients must call each January to request a new voucher for the new year.
Eversense PASS Savings Program
Experience the EVERSENSE® 365 CGM system for as low as $199 for a full year. This includes the cost of both CGM sensor and transmitter. Redemption - Eligible Patients will receive savings at point of purchase from a participating distributor. The Eversense PASS Program will be applied to eligible patients who purchase Eversense E3 CGM directly through a participating Strategic Fulfillment Partner. Patients will be informed of eligibility by the Strategic Fulfillment Partner when discussing out-of-pocket costs. Offer does not apply to the insertion and removal procedures.
Xeris Gvoke Hypopen
Eligible commercially insured (meaning not Medicare/Medicaid) patients may pay as little as $25 with a manufacturer Copay Card. For more info., visit https://www.gvokeglucagon.com/copay-card.
Call to request your Zegalogue® Savings Offer
If you have commercial insurance, such as insurance you receive through an employer, depending on your insurance coverage and out-of-pocket responsibility, you may pay $35 or $99 for each one-pack prescription for up to 48 months from date of Savings Offer activation. Call 1-833-992-3299 to request a Zegalogue® Savings Offer.
If you have insurance, you may be eligible for the Afrezza Savings Card that lets you pay as little as $35 for your prescription. To obtain your Afrezza Savings Card, sign up at the company's website at to register. You will receive your card via email or you can print a card. https://afrezza.com/savings-program/
Reduced Rx
CVS Caremark offers a coupon program for certain, older biosynthetic insulins in 10 mL vial formats from Novo Nordisk (Novolin products) for $25/vial when bought from CVS. The discounts apply to Novolin R, Novolin N and Novolin 70/30 pre-mixed varieties. Click the image or visit https://www.reducedrx.com/
Lilly Direct Online Pharmacy
Transparent pricing and choice to use major insurance plans or opt for self-pay (select medicines are available only through self-pay, although self-pay is often much less costly than using insurance), with all avail. mfg. coupons applied. Click the image, or visit https://lillydirect.lilly.com/pharmacy
“Living with diabetes is like living with a tiger. If you feed it, groom it, never turn your back on it; you can live with a tiger. If you neglect it; it'll pounce on you and rip you to shreds.”
4 comments:
Nice summary Scott. And thanks for the shout-out to all of our previous posts. Looking forward to seeing you again next year (?)
Best,
AmyT
Scott thanks for an excellent summary of what went on. I really like the idea of someone (ADA/JDRF/an other) supporting medical students so that becoming an endo is more attractive financially. I also think that there should be more training for people with diabetes to enable them to help others with diabetes. Kind of like a mini CDE, that might help to slightly relieve the shortage of endos,
Scott,
I'm over at a fellow diabetic friend's house visiting and we were looking at your blogsite and both agreed that it is one of the best around.
Thank you so much for your thorough firsthand report here, links included in it, and your always excellent blogsite in total. Because of your hard work diabetics everywhere are better off. You are the real diabetes superhero!
Brad Slaight (a.k.a. Meter Boy)
Hi Scott,
Ambre Morley from Novo Nordisk. Your characteristic of our use of Twitter with Charlie Kimball is not quite how we see it, as Twitter is only one small element of the much larger, Race with Insulin campaign.
There were several follow ups to the article you posted and I'd like to share with you the overall diabetes awareness campaign that we think has had a big impact. Please let me know at abmo at novonordisk.com if you'd like to discuss.
Thanks,
Ambre Morley
Associate Director, Product Communications
Novo Nordisk
Post a Comment